Literature DB >> 23493732

Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts.

Andreas Charidimou1, Puneet Kakar, Zoe Fox, David J Werring.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate cerebral microbleeds (CMBs) and future stroke risk (including intracerebral hemorrhage [ICH]) in patients with ischemic stroke (IS) or transient ischemic attack.
MATERIALS AND METHODS: A systematic review and meta-analysis of prospective cohorts with recent IS/transient ischemic attack. We critically appraised studies and calculated pooled odds ratios (ORs), using the Mantel-Haenszel fixed-effects method, for ICH or recurrent IS, in patients with versus without CMBs.
RESULTS: We pooled data from 10 cohorts, including 3067 patients. CMBs were associated with a significant increased risk of any recurrent stroke (OR, 2.25; 95% confidence interval [95% CI], 1.70-2.98; P<0.0001), ICH (OR, 8.52; 95%CI, 4.23-17.18; P=0.007), and IS (OR, 1.55; 95%CI, 1.12-2.13; P<0.0001). When stratified by study population ethnicity (Asian versus Western [mainly white European]), the association of CMBs with ICH was significant for Asian cohorts (5 studies; n=1915; OR, 10.43; 95%CI, 4.59-23.72; P<0.0001) but borderline and of lower magnitude for Western cohorts (4 studies; n=885; OR, 3.87; 95%CI, 0.91-16.4; P=0.066). By contrast, there was a significant association of CMBs with recurrent IS in Western (3 studies; n=899) but not Asian cohorts (4 studies; n=1357; OR, 2.23; 95%CI, 1.29-3.85; P=0.004 compared with OR, 1.30; 95%CI, 0.88-1.93; P=0.192, respectively).
CONCLUSIONS: There is consistent evidence of an increased risk of recurrent stroke after IS or transient ischemic attack in patients with CMBs. The risk for spontaneous ICH appears to be greater than the risk for recurrent IS. Our findings also suggest that the balance of risk for ICH versus IS differs between Asian and Western cohorts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23493732     DOI: 10.1161/STROKEAHA.111.000038

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  72 in total

1.  Cerebral Microbleeds as Predictors of Mortality: The Framingham Heart Study.

Authors:  José R Romero; Sarah R Preis; Alexa Beiser; Jayandra J Himali; Ashkan Shoamanesh; Philip A Wolf; Carlos S Kase; Ramachandran S Vasan; Charles DeCarli; Sudha Seshadri
Journal:  Stroke       Date:  2017-01-31       Impact factor: 7.914

2.  Factors associated with the new appearance of cerebral microbleeds after endovascular treatment for unruptured intracranial aneurysms.

Authors:  Eiji Higashi; Taketo Hatano; Mitsushige Ando; Hideo Chihara; Takenori Ogura; Keita Suzuki; Keitaro Yamagami; Daisuke Kondo; Takahiko Kamata; Shota Sakai; Hiroki Sakamoto; Izumi Nagata
Journal:  Neuroradiology       Date:  2021-01-07       Impact factor: 2.804

3.  Management of acute intracerebral haemorrhage - an update.

Authors:  Zhe Kang Law; Jason P Appleton; Philip M Bath; Nikola Sprigg
Journal:  Clin Med (Lond)       Date:  2017-04       Impact factor: 2.659

Review 4.  Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk Updated meta-analysis.

Authors:  Andreas Charidimou; Ashkan Shoamanesh; Duncan Wilson; Qiang Gang; Zoe Fox; H Rolf Jäger; Oscar R Benavente; David J Werring
Journal:  Neurology       Date:  2015-09-15       Impact factor: 9.910

5.  Cerebral microbleeds and risk of incident dementia: the Framingham Heart Study.

Authors:  José R Romero; Alexa Beiser; Jayandra J Himali; Ashkan Shoamanesh; Charles DeCarli; Sudha Seshadri
Journal:  Neurobiol Aging       Date:  2017-03-06       Impact factor: 4.673

6.  Cystatin C promotes cognitive dysfunction in rats with cerebral microbleeds by inhibiting the ERK/synapsin Ia/Ib pathway.

Authors:  Guangna Yu; Xingyuan Sun; Li Li; Lijuan Huang; Hongbin Liu; Shuying Wang; Zhanjun Ren; Yanjiao Zhang
Journal:  Exp Ther Med       Date:  2019-12-31       Impact factor: 2.447

7.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

Authors:  Stéphanie Debette; Sabrina Schilling; Marie-Gabrielle Duperron; Susanna C Larsson; Hugh S Markus
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 8.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

9.  Underlying embolic and pathologic differentiation by cerebral microbleeds in cryptogenic stroke.

Authors:  Muneaki Kikuno; Yuji Ueno; Takahiro Shimizu; Ayako Kuriki; Yohei Tateishi; Ryosuke Doijiri; Yoshiaki Shimada; Hidehiro Takekawa; Eriko Yamaguchi; Masatoshi Koga; Yuki Kamiya; Masafumi Ihara; Akira Tsujino; Koichi Hirata; Kazunori Toyoda; Yasuhiro Hasegawa; Hitoshi Aizawa; Nobutaka Hattori; Takao Urabe
Journal:  J Neurol       Date:  2020-02-03       Impact factor: 4.849

10.  Cerebral Microbleeds on MRI in Patients with Obstructive Sleep Apnea.

Authors:  Dae Lim Koo; Jun Yup Kim; Jae-Sung Lim; Hyung-Min Kwon; Hyunwoo Nam
Journal:  J Clin Sleep Med       Date:  2017-01-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.